FDA proposes framework clinical trial designs to guide Bayesian methods, improving efficiency in drug development for rare and pediatric conditions.
The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...
Viking Therapeutics, Inc. (NASDAQ:VKTX) is one of the best US stocks to buy under $50. On January 12, Viking Therapeutics, ...
A new analysis of drug trials used to approve medicines in the United States shows how far modern medicine still has to go to ...
Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...
The pharmaceutical industry is experiencing its own “DeepSeek moment,” according to science writer Hiya Jain. Just as the upstart AI breakthrough caught Silicon Valley off-guard, China is emerging as ...
The Centre amends drug rules, streamlining approval processes and reducing timelines to enhance clinical research and ...
Biopharmaceutical artificial intelligence startup Owkin Inc. said today it’s making a series of autonomous agents focused on drug discovery and research available to the broader healthcare industry, ...
In a major regulatory reform aimed at accelerating pharmaceutical research and easing compliance, the Union ministry of ...
The Union Ministry of Health and Family Welfare has taken a series of measures including simplification of regulatory processes and reduction of drug approval timelines to facilitate and speed up the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results